Search

everythinglearnresearchcommunity

for

Search:↓

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Par3–mInsc and Gαi3 work together to ensure proper cell division orientation in skin development.

miRNAs in the Dlk1-Gtl2 region may improve lamb fur quality.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Phosphorylation of certain parts of the PIN3 protein is crucial for its role in plant root growth and response to gravity.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

MOF controls skin development by regulating genes for mitochondria and cilia.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

MOTILIPERM may help treat male infertility by reducing stress in cells.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

Aptamers can improve wound healing and promote hair growth.